A widely used blood pressure medication has been recalled after testing showed it may have been cross-contaminated with another drug, according to multiple national reports.
Glenmark Pharmaceuticals has recalled more than 11,100 bottles of bisoprolol fumarate and hydrochlorothiazide tablets, which are sold under the brand name Ziac. The recall was first reported by USA Today.
Testing of reserve samples found traces of ezetimibe, a cholesterol-lowering medication also produced by Glenmark. The discovery prompted the company to remove affected lots from the market while the issue is investigated.
According to The Hill, the U.S. Food and Drug Administration said the recall covers the following Ziac products:
- 30-count bottles, NDC 68462-878-30
- 100-count bottles, NDC 68462-878-01
- 500-count bottles, NDC 68462-878-05
The impacted lots were scheduled to expire between November 2025 and May 2026.
The FDA said the medicine is not expected to cause adverse health consequences for most patients. However, the agency has not yet issued guidance on what patients should do if they believe their medication is part of the recall.
Consumers who take Ziac are encouraged to check the lot numbers on their prescription bottles and contact their pharmacy or healthcare provider with any concerns.